Enlife Global

Enlife is committed to providing a diverse range of healthcare and aesthetics related products to our customers. We believe that every human being should be given an opportunity to live life to the fullest…to sustainably experience life at the best physical and mental state possible. Our Vision: “We will be one of the most trusted healthcare and personal care companies in the Philippines and in Asia. Our company would be synonymous to high quality, high efficacy, lifesaving or life enhancing products.” We plan to launch a broad range of healthcare and aesthetics related life-saving or life-enhancing products. Product categories in the market or at immediate development phase are the following: 1) Food supplements to aid: Anti-Aging Overweight and Obesity Irritable Bowel Syndrome (IDS) Managing metabolic syndrome related diseases 2) Sterile IV (Injectable) Pharmaceuticals; Septic Shock, Multiple Sclerosis, Anesthesia, Analgesics, Sedation 3) Medical devices: IV infusion related; Novel delivery systems EnLife Global Incorporated is listed with the Philippines’ Securities and Exchange Commission with Company Registration number CS201405215. Also, it is duly registered with the Bureau of Internal Revenue with Tax Identification number 008-735-678. With the intended business purpose of: Importation, Distribution, Marketing and Trading of Drugs/Medicines, Medical Supplies and Devices, food/food items and cosmetics Enlife Global is an accredited importer by the Philippines Bureau of Customs. The Company has the following valid License to Operate (LTO’s) from the Philippines’ Food and Drug Administration (FDA) License to Operate as an Drug Distributor/Importer FDA LTO No. : CDRR-NCR-DI-4209 License to Operate as Medical Device Importer; FDA LTO No.: 3000001666077 License to Operate as a Food Distributor / Importer / Wholesaler; LTO No.: CFRR-NCR-FI/W-5779 EnLife company president, Allan G. Almazar is an experienced marketer in the Healthcare space in the Philippines and other markets in Asia. His most recent responsibility as was as Country Manager of Hospira Philippines from 2006 to 2013. A few of his Key Achievements –  Led Philippine operations to improve its market ranking from being 23rd at launch to 6th by 2013, based on the IMS PHPA 2Q 2013 MAT Market Audit, and to be consistently in the top 10 market drivers in the annual IMS Audit, by developing an aggressive product launch pipeline and focusing on strategic markets.  Developed the Philippine business to be a strong market challenger or dominant player positions in both established or newly entered market segments/channels – Acute Care Specialty Pharma, Infusion Pumps & Devices, Needle-Less Systems.  Drove the Philippine business to be the 2nd biggest affiliate, in terms of revenue for Hospira Asia/Greater China Region and #1 in margin contribution.  Affiliate with the highest 5-year revenue & net income CAGR of all spun off entities (doubled the size of revenue in 3 years of operations and tripled this in 7 years) Prior to Hospira, he was running the fastest growing division of Abbott Philippines - The Hospital care division as its Marketing Director. Some of his key achievements –  Led the Division to an 18% 3-year top line sales compounded growth rate; Division revenue of PhP1B by end 2004.  Drove all managed franchises to leadership positions – Medical Nutrition, Anesthetics, Cardio Inotropes.  Consistently delivered bottom line plan commitments, through portfolio optimization and new product introductions.  Achieved an industry high of PhP23.7MM sales force productivity.